Inhibrx Biosciences (INBX) Other Non-Current Assets (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Other Non-Current Assets data on file, last reported at $4.4 million in Q4 2025.

• On a quarterly basis, Other Non-Current Assets fell 35.91% year-over-year to $4.4 million in Q4 2025; TTM through Dec 2025 was $4.4 million, a 35.91% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 35.91% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $4.4 million, down from $5.7 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for INBX reached as high as $6.8 million in Q4 2024 and fell as low as $3.2 million in Q4 2023.
• Historically, Other Non-Current Assets has averaged $5.9 million across 3 years, with a median of $6.7 million in 2024.
• Across the five-year window, Other Non-Current Assets surged 115.9% in 2024 and tumbled 35.91% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $3.2 million in 2023, then jumped by 115.9% to $6.8 million in 2024, then sank by 35.91% to $4.4 million in 2025.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $4.4 million in Q4 2025, $5.7 million in Q3 2025, and $6.8 million in Q2 2025.